Especially, the potential mechanism that could control TGF-β/Smad3 to switch from anti- to pro-tumorigenic role will also be focused in our future study, which is expected to provide us with some improvements on clinical methods for both diagnosis and combinatorial cancer chemotherapies. The gene discussed is SMAD3; the disease is cancer.